Position: Director, Health Economics (full-time, home-based)

MTRC is pleased to announce the release of its latest White Paper: "Transitional Coverage of Innovative Medical Devices in France (pre-LPPR)". This White Paper is designed for medical device manufacturers, market access experts, and health policy leaders who are shaping strategies for early adoption in the French market.

MTRC is pleased to announce the release of its latest White Paper: "Evidence requirements for the creation of IVD reimbursement (NABM) codes in France". This document sheds light on the broader evidence requirements and decision-making framework used by HAS, offering diagnostics manufacturers critical insights into the expectations and potential challenges of securing NABM reimbursement.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better. From the week of the 19th of May, we plan to work on 17 projects. Review the complete list of planned activities in this post.

MTRC is pleased to introduce a new service to help bridge the gap between clinical research and the evidence expectations of European HTA and reimbursement bodies.

MTRC is pleased to announce the release of its latest White Paper: "Best Reporting Checklists for Studies of Medical Devices". This White Paper explores the best reporting checklists for medical device studies (CONSORT, STROBE, STARD, PRISMA, PRISMA-DTA, SPIRIT, and TIDieR), their key components, and how they improve research transparency.